How E-Cigarette Flavors Affect Men and Women Who Smoke
Sex Differences in E-Cigarette Flavor Sensory Perception As It Relates to Appeal and Reinforcing Efficacy Among Adult Smokers
This project looks at how different e-cigarette flavors, like sweet or cooling, are experienced by adult male and female smokers and how these flavors might influence their desire to use e-cigarettes.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11124912 on NIH RePORTER |
What this research studies
We know that women who smoke might be more sensitive to non-nicotine sensations, which could make it harder for them to quit or respond to nicotine replacement. This project explores how adult men and women who smoke perceive popular e-cigarette flavors, such as sweet and cooling, and how these perceptions affect how appealing and reinforcing e-cigarettes become. We will offer different e-cigarette flavors (sweet, cooling, and unflavored) with a moderate nicotine level, both alone and with or without nicotine, to understand their impact. Our goal is to see if women have a stronger response to these flavors compared to men, which could help explain differences in e-cigarette use.
Who could benefit from this research
Good fit: Ideal candidates for this type of research would be adult male and female cigarette smokers, aged 21 and older.
Not a fit: Individuals who do not smoke or use e-cigarettes, or those under 21, would not directly benefit from participating in this specific research.
Why it matters
Potential benefit: Understanding how e-cigarette flavors affect men and women differently could lead to more effective strategies for helping people quit smoking or reduce e-cigarette use.
How similar studies have performed: Previous research has indicated sex differences in sensitivity to non-nicotine cues and e-cigarette flavor preferences, suggesting this approach builds on existing findings.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Davis, Danielle R — Yale University
- Study coordinator: Davis, Danielle R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.